Overview

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

Status:
Completed

Trial end date:
2019-11-20

Target enrollment:

Participant gender:

Summary

This is an multicenter, randomized, double-blind, parallel-controlled study to evaluated the efficacy of pioglitazone hydrochloride and metformin hydrochloride tablets on the patients with newly diagnosed type 2 diabetes mellitus combined with non-alcoholic fatty liver disease.

Phase:

Phase 4

Details

Lead Sponsor:

Xijing Hospital

Collaborators:

Chang'An Hospital
Genertec Universal Xi'an Aero-Engine hospital (Xi' an) Co., Ltd
Second Affiliated Hospital of Xi'an Jiaotong University
Shaanxi Aerospace Hospital
Shangluo Central Hospital
Xi'an Gaoxin Hospital
Yan'an people's Hospital

Treatments:

Metformin
Pioglitazone